Table 1 Baseline characteristics of patients

Age, years*

56 (34–82)

Male gender, n (%)

93 (80)

Etiology, n (%)

HBV/HCV/alcohol/others

79/6/18/13 (68/5/16/11)

Child-Pugh classification, n (%)

A/B

77/39 (66/34)

ECOG performance status, n (%)

0-1/2

88/28 (76/24)

History of prior treatment, n (%)

66 (57)

Modified UICC stage, n (%)

II/III/IVa/IVb

2/26/30/58 (2/22/26/50)

BCLC stage, n (%)

B/C/D

19/93/4(16/80/4)

AFP, ng/dL*

124 (1–150000)

Macrovascular invasion, n (%)

64 (55)

Extrahepatic metastasis, n (%)

54 (46)